Navigation Links
Cure for cancer one step closer

The cure for cancer is one step closer this week with the first collections of cancer tissue taking place at the new Wesley Research Institute Tissue Bank.

The Tissue Bank is the first of its kind in Queensland to provide a widely available and diversified collection of ethically consented and clinically annotated tissue, helping to unravel the cause, progression and potential treatment for cancer and other diseases.

Professor Julie Campbell AO, Director of The Wesley Research Institute, said the current absence of large, high quality cancer tissue and blood collections with clinical data is a major barrier to improving care of cancer patients.

"Queensland research has taken an enormous step forward this week. There is every possibility that findings made achievable by the Tissue Bank will lead to the next big breakthrough in the fight against cancer," she said.

"By providing researchers who are part of an ethically and scientifically approved research project with tissue, matching blood samples and full clinical data, valuable funds will be saved, which can then be applied to further their research.

"There is compelling evidence that new methods for screening, diagnosis and evaluation of cancer can make a significant impact on cancer care in the immediate future," Professor Campbell said.

Dr John Lumley, a surgeon from The Wesley Hospital, said that these specimens would be donated by consenting patients during the course of their normal treatment.

"I encourage patients and surgeons to support the important work of the Tissue Bank because everybody can play a part in the cure. Every cell contains a clue that can make a difference to tomorrow's cancer patients," he said.

Queensland is well placed as a source of cancer tissue due to its diverse population, large number of aged retirees, and high-rate of some cancers, particularly melanoma. The Wesley Hospital alone had almost 2000 cancer rel ated surgeries in 2004.

The Queensland Government contributed $1.42 million towards the construction of the Tissue Bank through the Smart State Research Facility Fund.

The investment has built and equipped, as part of the Institute's infrastructure, a dedicated laboratory with highprecision equipment for preparation and study of tissue samples.

This equipment includes an Aperio Scan Scope which takes high resolution images of tissue samples that can then be shared with researchers around the world, and two vapour phase nitrogen storage vessels (-196ºC) and two -80ºC freezers which have the capacity to house in excess of 164,000 tissue and blood samples.

The small sections of tissue collected from patients will be stored in cryogenic vials which will help preserve the tissue's proteins and genetic material almost indefinitely.

The Wesley Research Institute is a leading medical research facility with a commitment to patient care, ethical conduct and quality research that aims to improve quality of life through better diagnosis and treatment.


'"/>

Source:Research Australia


Related biology news :

1. Viral DNA sequence a possible trigger for breast cancer
2. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
3. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
4. Columbia research lifts major hurdle to gene therapy for cancer
5. Combination therapy boosts effectiveness of telomere-directed cancer cell death
6. Mitochondrial DNA mutations play significant role in prostate cancer
7. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
8. BRCA1 causes ovarian cancer through indirect, biochemical route
9. Researchers identify target for cancer drugs
10. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
11. First atlas of key brain genes could speed research on cancer, neurological diseases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
Breaking Biology Technology: